These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18759649)

  • 1. Prior treatment with stimulant medication: a much neglected confounder of studies of growth in children with attention-deficit/hyperactivity disorder.
    Poulton AS; Nanan R
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):385-7. PubMed ID: 18759649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of growth in stimulant-naive children with attention-deficit/hyperactivity disorder by using cross-sectional and longitudinal approaches.
    Poulton A; Nanan R
    Pediatrics; 2008 Jul; 122(1):221; author reply 221-2. PubMed ID: 18596017
    [No Abstract]   [Full Text] [Related]  

  • 4. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving psychostimulant adherence in children with ADHD.
    Charach A; Gajaria A
    Expert Rev Neurother; 2008 Oct; 8(10):1563-71. PubMed ID: 18928348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
    Mohammadi M; Akhondzadeh S
    Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Side Effect Profile of Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder in Youth with Epilepsy.
    Kral MC; Lally MD; Boan AD
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):735-740. PubMed ID: 28383998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder.
    Poulton A
    Curr Opin Pediatr; 2006 Aug; 18(4):427-34. PubMed ID: 16914999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder.
    Vaughan B; Kratochvil CJ
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):941-55. PubMed ID: 23040908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing attention-deficit/hyperactivity disorder in children and adolescents.
    McClain EK; Burks EJ
    Prim Care; 2015 Mar; 42(1):99-112. PubMed ID: 25634708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate?
    Wigal SB; Jun A; Wong AA; Stehli A; Steinberg-Epstein R; Lerner MA
    Postgrad Med; 2010 Sep; 122(5):27-34. PubMed ID: 20861585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
    Merkel RL
    Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does stimulant medication decrease the lower extremity response times of children with and without attention-deficit/hyperactivity disorder?
    Brasić JR
    Percept Mot Skills; 2007 Feb; 104(1):67-8. PubMed ID: 17450965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches.
    Hanć T; Cieślik J
    Pediatrics; 2008 Apr; 121(4):e967-74. PubMed ID: 18381524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.
    Brossard-Racine M; Shevell M; Snider L; Bélanger SA; Majnemer A
    Res Dev Disabil; 2012; 33(6):2080-7. PubMed ID: 22796639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
    Cohen-Zion M; Ancoli-Israel S
    Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review.
    Troksa K; Kovacich N; Moro M; Chavez B
    Pharmacotherapy; 2019 Jun; 39(6):665-676. PubMed ID: 30368860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.